Your session is about to expire
Terbinafine vs Tinactin
Introduction
For patients suffering from fungal infections such as athlete’s foot, jock itch or ringworm, certain antifungal medications can help in eradicating the fungi and alleviating symptoms. Terbinafine and Tinactin are two such drugs that are commonly used to treat these conditions. Both of them work by inhibiting a specific enzyme (squalene epoxidase) necessary for the fungus to grow, but they differ in their formulation, efficacy duration, and administration method. Terbinafine is an allylamine class antifungal that interferes with fungal sterol synthesis by inhibition of squalene epoxidase leading to ergosterol deficiency and an intracellular accumulation of squalene which results in fungal cell death. On the other hand, Tinactin (also known as Tolnaftate), while also being an antifungal medication, falls under a different chemical class (thiocarbamates) and its exact mechanism of action is not entirely clear; however it's primarily thought to inhibit the production of enzymes important for the growth of fungi.
Terbinafine vs Tinactin Side By Side
| Attribute | Lamisil | Tinactin |
|---|---|---|
| Brand Name | Lamisil | Tinactin |
| Contraindications | Should not be used by individuals allergic to it or with a history of liver disease without discussing it with a healthcare provider. | Should not be used by individuals allergic to it. Specific contraindications beyond allergies were not mentioned. |
| Cost | The price of 30 tablets of Lamisil (terbinafine 250 mg) averages around $450. Generic versions can range from $10–$100. | A tube of Tinactin cream (1% strength) costs an average of about $10. Generic equivalents are often cheaper, frequently available at under $5 per tube. |
| Generic Name | Terbinafine | Tolnaftate |
| Most Serious Side Effect | Liver damage, signs of an allergic reaction, severe skin reactions, changes in vision, rapid heartbeat or palpitations, shortness of breath, electrolyte imbalance, severe nervous system reaction. | Signs of an allergic reaction, severe skin reactions including itching, redness, burning sensation at the application site, increased sensitivity resulting in severe irritation and inflammation. |
| Severe Drug Interactions | Not explicitly mentioned, but it's noted that certain drugs can interact unfavorably with Terbinafine. | Not mentioned, likely due to its topical application and minimal systemic absorption. |
| Typical Dose | Oral dosages range from 250-500 mg/day, with 250 mg/day being sufficient for most people. | Applied to the affected area one to two times per day as needed. Treatment typically begins with a twice-daily application. |
What is Terbinafine?
Terbinafine (the generic name for Lamisil) is a synthetic allylamine antifungal medication which marked an important advancement from the original class of antifungal drugs, such as azoles. Terbinafine was first approved by the FDA in 1996. It works by inhibiting a vital enzyme that fungi need to create ergosterol, disrupting cell membrane function and causing fungal cell death. It is prescribed primarily for treating fungal infections of the nail and skin such as athlete's foot or ringworm. Terbinafine has selective inhibition on squalene epoxidase, with minimal effect on human sterol biosynthesis which results in it having fewer side effects than other antifungals that have stronger effects on this pathway.
On the other hand, Tinactin (also known as Tolnaftate), is another over-the-counter topical antimycotic treatment widely used for superficial skin infections caused by fungus like tinea pedis (athlete's foot), tinea cruris(jock itch), and tinea corporis(ringworm). Tinactin works differently from terbinafine; it prevents growth of fungi rather than killing them directly. Both are generally well tolerated but can cause some local irritation or burning sensation when applied topically.
What conditions is Terbinafine approved to treat?
Terbinafine is approved for the treatment of various types of fungal infections:
- Onychomycosis, a type of fungal nail infection
- Tinea Capitis, a scalp fungus often seen in children
- Dermatophytic Infections, such as athlete's foot (tinea pedis), jock itch (tinea cruris) and ringworm (tinea corporis)
- Cutaneous candidiasis, an infection caused by Candida yeast.
How does Terbinafine help with these illnesses?
Terbinafine helps to manage fungal infections by inhibiting the enzyme squalene epoxidase, which is crucial for ergosterol synthesis. Ergosterol is an important component of the fungal cell membrane and without it, the fungi cannot maintain their structure or function properly. Terbinafine works by blocking this critical process in the fungi's lifecycle so that they can't proliferate further. This disruption subsequently leads to an accumulation of squalene within the cell disrupting cellular function leading to death of fungus cells. It is thought that individuals with a fungal infection have relatively higher levels of these pathogenic organisms on their skin or nails. Therefore, by inhibiting ergosterol synthesis, Terbinafine can limit the negative effects of a fungal infection and help patients heal from their condition.
What is Tinactin?
Tinactin is a popular brand name for tolnaftate, an antifungal medication primarily used to treat skin infections like athlete's foot, jock itch, and ringworm. As an allylamine derivative, it works by inhibiting the enzyme squalene epoxidase, which disrupts fungal cell membrane production leading to the death of the fungus. Tinactin was first approved by FDA decades ago and has proven its effectiveness over time. Unlike terbinafine which is available in oral form and may cause systemic side effects such as gastrointestinal disturbance or taste disturbances due to its action on liver enzymes; Tinactin is mostly available in topical forms (cream, spray), minimizing potential side effects since it does not enter your system but acts locally at the site of application. The local action minimizes systemic exposure thus reducing chances of adverse events making it a preferred choice for many patients with superficial skin fungal infections.
What conditions is Tinactin approved to treat?
Tinactin is an over-the-counter antifungal medication that has been approved for the treatment of a variety of superficial fungal infections, including:
- Athlete's foot (tinea pedis)
- Jock itch (tinea cruris)
- Ringworm (tinea corporis) It can also be used as a preventative measure to avoid these common and uncomfortable conditions.
How does Tinactin help with these illnesses?
Tinactin, also known as tolnaftate, is an antifungal medication that works by preventing the growth of fungus. It’s a solid choice for treating conditions such as athlete's foot, jock itch and ringworm. It interrupts fungal cell growth and prevents reproduction by binding to keratin in skin or nails. This gives it a unique advantage over terbinafine since it can treat both superficial fungal infections and those that are slightly deeper within the nail bed. Tinactin does not have notable side effects or systemic absorption when applied topically, making it generally safe for most patients. Furthermore, its effectiveness on various types of fungi allows healthcare providers to prescribe Tinactin even if the exact type of fungus causing your infection has not been identified – something which cannot always be done with terbinafine.
How effective are both Terbinafine and Tinactin?
Both terbinafine and tolnaftate (Tinactin) are antifungal medications that have been used for decades to treat various types of fungal infections, including athlete's foot, jock itch, and ringworm. Terbinafine was approved by the FDA in 1996 while Tinactin received its approval even earlier in 1965. Both act on different aspects of fungal cell metabolism; terbinafine inhibits squalene epoxidase, an important enzyme in fungal sterol biosynthesis whereas Tinactin works by distorting the hyphae and stunting mycelial growth in susceptible fungi.
Clinical studies directly comparing these two drugs found no significant differences between them regarding their efficacy or safety profiles. However, some side effects like gastrointestinal symptoms were somewhat more common with oral terbinafine compared to topical Tinactin application.
A meta-analysis conducted in 2002 revealed that terbinafine is effective at treating dermatophyte infections from the first week of treatment onward. It has a favorable side effect profile over many other antifungal medicines when taken orally but can cause liver damage if not monitored closely.
On the other hand, a review from 2010 indicated that although Tinactin appears less potent than newer antifungals like azoles or allylamines (such as terbinafine), it remains a viable option for mild-to-moderate superficial skin infections due to its minimal systemic absorption when applied topically - making it safer for long-term use or prophylaxis against recurrence.
Related trials for terbinafine and tinactin
Find Top Clinical Trials
Choose from over 30,000 active clinical trials.
At what dose is Terbinafine typically prescribed?
Oral dosages of Terbinafine range from 250-500 mg/day, but studies have indicated that 250 mg/day is sufficient for treating fungal infections in most people. Children and adolescents may be started on a lower dose depending on their weight and the severity of the infection. In either population, dosage can be increased after a few weeks if there is no response. The maximum dosage that should not be exceeded in any case is 500 mg/day. On the other hand, Tinactin (tolnaftate) is typically used topically rather than orally, applied to the affected area one to two times per day as needed.
At what dose is Tinactin typically prescribed?
Tinactin treatment for fungal infections of the skin, such as athlete's foot and jock itch, typically begins with a twice-daily application of the product to clean, dry skin. This involves applying a thin layer of Tinactin to the affected area in the morning and at night. If there is no improvement observed after two weeks of consistent use, you may need to consult your healthcare provider for further assessment. For best results against stubborn infections, continue using Tinactin for another week even after symptoms have resolved. The aim is not only to alleviate symptoms but also prevent recurrence by eliminating fungi completely.
What are the most common side effects for Terbinafine?
Typical side effects of Terbinafine include:
- Headache
- Diarrhea, upset stomach or indigestion
- Rash, itching or hives
- Changes in taste
- Loss of appetite
On the other hand, Tinactin generally has fewer systemic side effects as it is a topical medication. However, localized skin reactions such as burning, stinging or redness at the application site may occur. Always consult with your healthcare provider regarding any concerns about potential side effects when considering these treatments for fungal infections.
Are there any potential serious side effects for Terbinafine?
While Terbinafine is generally well tolerated, it can occasionally cause side effects that require immediate medical attention. Here are some severe reactions to look out for:
- Signs of an allergic reaction: hives; difficult breathing; swelling in your face, lips, tongue or throat.
- Symptoms related to skin problems such as rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, and trouble breathing
- Changes in vision like blurred vision or double vision
- Rapid heartbeat or palpitations
- Shortness of breath and signs suggestive of lung infection like cough and fever
- Electrolyte imbalance - symptoms might include feeling tired or thirsty, muscle cramps/weakness/spasms
- Severe nervous system reaction – rigid muscles, high fever, sweating confusion rapid heartbeats
Moreover, liver damage has been associated with terbinafine. If you notice any symptoms such as persistent nausea/vomiting/loss of appetite/stomach pain/yellowing eyes/dark urine/pale stools/fatigue seek medical help right away.
It's important to remember that these side effects are rare and most people use Terbinafine without experiencing serious issues. But if you do experience any unusual symptoms after starting this medication contact your healthcare provider immediately.
What are the most common side effects for Tinactin?
In the comparison between Terbinafine and Tinactin, it's important to note that Tinactin can lead to certain side effects which include:
- Mild skin irritation or burning sensation at the application site
- Dryness of treated skin
- Unusual redness or peeling of skin
- Increased sensitivity to sunlight
However, these are typically less severe than those experienced with Terbinafine. Unlike oral antifungal drugs such as Terbinafine, topical treatments like Tinactin usually do not cause systemic side effects like upset stomach, loss of appetite or headache. Nevertheless, if any discomfort arises while using Tinactin or if your symptoms do not improve within a week (for athlete's foot and ringworm) or 2 weeks (for jock itch), you should contact your healthcare provider.
Are there any potential serious side effects for Tinactin?
While Tinactin is generally well-tolerated, it's important to be aware of potential side effects that could indicate a more serious reaction. These include:
- Signs of an allergic reaction such as hives; difficulty breathing; swelling in your face, lips, tongue or throat
- Severe skin reactions including itching, redness, burning sensation at the application site
- Increased sensitivity where the medicine was applied resulting in severe irritation and inflammation
- Symptoms suggestive of systemic absorption like dizziness or nausea.
If you experience any of these symptoms after using Tinactin, stop its usage immediately and seek medical attention right away.
Contraindications for Terbinafine and Tinactin?
Both Terbinafine and Tinactin, like most antifungal medications, may cause some side effects. If you notice any serious or adverse reactions such as severe skin irritation, redness, swelling or worsening of the infection after using these products, please seek immediate medical attention.
Neither Terbinafine nor Tinactin should be used if you are allergic to them or have a history of liver disease without discussing it with your healthcare provider. Ensure that your physician is aware of all the medications you're taking; certain drugs can interact unfavourably with Terbinafine and Tinactin.
Terbinafine tablets need to be taken for a longer period (usually 6 weeks to 12 weeks), while topical forms like creams and gels are generally applied once or twice daily till one week after the symptoms disappear. On the other hand, Tinactin is usually applied twice daily for two weeks (for jock itch and athlete's foot) and for four weeks (for ringworm).
As always in case of doubts about which medication would work best on your fungal infection, consult with a healthcare professional.
How much do Terbinafine and Tinactin cost?
For the brand name versions of these antifungal drugs:
- The price of 30 tablets of Lamisil (terbinafine 250 mg) averages around $450, which works out to about $15/day.
- A tube of Tinactin cream (1% strength) costs an average of about $10 for a supply that should last you several weeks.
Therefore, if your fungal infection requires oral medication and is widespread or severe enough to need treatment with terbinafine, then it will be significantly more expensive than using topical tinactin. However, the choice between these treatments is dictated by the type and severity of your condition rather than cost considerations alone.
As for generic versions:
- Generic terbinafine can lower this cost considerably: packages range from $10–$100 depending on quantity and dosage. This could mean daily costs as low as $0.20–$2.
- There are also numerous generic equivalents available for tinactin (tolnaftate), which are often cheaper still — frequently available at under $5 per tube.
Popularity of Terbinafine and Tinactin
Terbinafine, available under brand names such as Lamisil, was estimated to have been prescribed to about 6 million people in the US in 2020. Terbinafine accounted for approximately 15% of antifungal prescriptions in the US. It is particularly well-suited for treating onychomycosis (fungal nail infection) due to its ability to concentrate within keratinous tissues and has seen a general increase in prevalence since 2013.
Tolnaftate, sold amongst others under the brand name Tinactin, doesn't require a prescription and thus exact usage numbers are hard to estimate but it's undoubtedly widely used across America. In contrast with terbinafine which is taken orally, Tinactin comes mainly as topical formulations like creams or powders that are applied directly onto affected areas making it easier and safer for most minor fungal skin infections such as athlete's foot or jock itch.
Conclusion
Both Terbinafine and Tinactin (tolnaftate) are antifungal medications commonly used to treat skin infections such as athlete's foot, jock itch, and ringworm. They have a long track record for safety and effectiveness in managing these conditions. Both drugs work by inhibiting the growth of fungi but they achieve this through different mechanisms of action; terbinafine interferes with fungal cell membrane synthesis while tolnaftate disrupts the enzyme squalene epoxidase.
Terbinafine is often considered a first-line treatment option due to its broad-spectrum antifungal activity against dermatophytes that cause common skin infections. On the other hand, Tinactin may be chosen for mild cases or when cost is a major consideration as it tends to be less expensive.
Both medications come in over-the-counter topical forms including creams, ointments, sprays and powders which can provide significant cost savings especially for patients who must pay out-of-pocket. In some instances, oral prescription versions of terbinafine may be necessary for severe or stubborn infections.
The side effect profile between the two drugs is similar with local irritation being most common but generally well-tolerated. However, oral terbinafine carries more potential risks including liver damage so monitoring is required during treatment.
For both drugs effective treatment requires regular application typically over several weeks; discontinuation upon initial signs of improvement could lead to recurrence of infection. If symptoms persist after recommended treatment duration consult your healthcare provider promptly.
Other Trials to Consider
Popular Categories
Popular Guides
Learn More About These Treatments
Refrences
- RYDER, N. S. (1992, February). Terbinafine: Mode of action and properties of the squalene epoxidase inhibition. British Journal of Dermatology. Oxford University Press (OUP).http://doi.org/10.1111/j.1365-2133.1992.tb00001.x
- Popovich, N. G. (1994, August). Topical OTC Antifungal Agents. American Pharmacy. Elsevier BV.http://doi.org/10.1016/s0160-3450(15)30336-6
- Balfour, J. A., & Faulds, D. (1992, February). Terbinafine. Drugs. Springer Science and Business Media LLC.http://doi.org/10.2165/00003495-199243020-00010
- Carnio, L. R., Johnson Shaw, M. E., Schnur, J., & Casadesus, D. (2021, January). Concurrent terbinafine-induced acute generalised exanthematous pustulosis and hepatitis. BMJ Case Reports. BMJ.http://doi.org/10.1136/bcr-2020-238930
- Krishnan-Natesan, S. (2009, October 30). Terbinafine: a pharmacological and clinical review. Expert Opinion on Pharmacotherapy. Informa UK Limited.http://doi.org/10.1517/14656560903307462
- AbouSamra, M. M., & Salama, A. H. (2016, October 19). Enhancement of the topical tolnaftate delivery for the treatment of tinea pedis <i>via</i> provesicular gel systems. Journal of Liposome Research. Informa UK Limited.http://doi.org/10.1080/08982104.2016.1239634
- Sigurgeirsson, B., Elewski, B. E., Rich, P. A., Opper, C., Cai, B., Nyirady, J., & Bakshi, R. (2006, January 1). Intermittent versus continuous terbinafine in the treatment of toenail onychomycosis: A randomized, double‐blind comparison. Journal of Dermatological Treatment. Informa UK Limited.http://doi.org/10.1080/09546630500504713
- Gupta, Lynde, Lauzon, Mehlmauer, Braddock, Miller, … Shear. (1998, March). Cutaneous adverse effects associated with terbinafine therapy: 10 case reports and a review of the literature. British Journal of Dermatology. Oxford University Press (OUP).http://doi.org/10.1046/j.1365-2133.1998.02140.x
- Gupta, A. K., Konnikov, N., & Lynde, C. W. (2001, March). Single-blind, randomized, prospective study on terbinafine and itraconazole for treatment of dermatophyte toenail onychomycosis in the elderly. Journal of the American Academy of Dermatology. Elsevier BV.http://doi.org/10.1067/mjd.2001.110874